Home/Filings/4/0001104659-19-030358
4//SEC Filing

Gionco David 4

Accession 0001104659-19-030358

CIK 0001264587other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 9:29 PM ET

Size

4.9 KB

Accession

0001104659-19-030358

Insider Transaction Report

Form 4
Period: 2019-05-03
Gionco David
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2019-05-03+15,000239,938 total
Footnotes (2)
  • [F1]Represents restricted shares that were subject to a performance-based milestone, which occurred on May 3, 2019. The restricted shares will vest one-third (5,000 shares) on each of May 3, 2020, 2021 and 2022, conditioned on the reporting person's continued service.
  • [F2]Of the 239,938 shares, 189,907 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001456864

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:29 PM ET
Size
4.9 KB